Keyphrases
Interleukin-1β
100%
Inflammation
100%
S100A8
100%
Cardiotoxicity
100%
NOD-like Receptor Protein 3 (NLRP3)
100%
Ponatinib
100%
Mouse Model
20%
Tyrosine Kinase Inhibitor
20%
Cardiac Dysfunction
20%
Systemic Inflammation
10%
Treatment Options
10%
Toll-like
10%
Dysregulated
10%
Molecular Mechanism
10%
RNA-seq Analysis
10%
Specific Inhibitor
10%
Myeloid Cells
10%
Signaling Pathway
10%
Clinical Investigation
10%
Preclinical Data
10%
Novel Mechanism
10%
In Vivo Model
10%
Chronic Myeloid Leukemia
10%
Interleukin-1 Signaling
10%
Leukemia Patients
10%
S100A9
10%
World Health Organization
10%
Cardio-oncology
10%
Myocardial Inflammation
10%
Toll-like Receptor 4 (TLR4)
10%
Pathological Phenotype
10%
Cardiac Pathology
10%
Cardiovascular Comorbidities
10%
Inflammatory Genes
10%
Excessive Inflammation
10%
Oncology Studies
10%
Gatekeeper mutation
10%
Alarmins
10%
Cardiac Inflammation
10%
T315I
10%
Multi-fold
10%
Paquinimod
10%
IL Interleukin
10%
Model Evidence
10%
CY-09
10%
Pharmacovigilance Analysis
10%
Medicine and Dentistry
Interleukin-1
100%
Cardiotoxicity
100%
Ponatinib
100%
NLR Family Pyrin Domain containing 3
100%
In Vitro
20%
Immunosuppressive Drug
20%
Toll Like Receptor 4
20%
Tyrosine-Kinase Inhibitor
20%
Interleukin 1
10%
Cardiovascular System
10%
RNA Sequence
10%
Upregulation
10%
Myeloid Cell
10%
Oncology
10%
Glucocorticoid
10%
Cell Signaling Pathway
10%
Dexamethasone
10%
Chronic Myelogenous Leukemia
10%
Cardiac Pathology
10%
Cardiotoxin
10%
Alarmin
10%
Carditis
10%
Paquinimod
10%
Pharmacovigilance
10%
Comorbidity
10%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Cardiotoxicity
100%
Ponatinib
100%
Mouse Model
20%
Immunosuppressive Agent
20%
Toll Like Receptor 4
20%
Protein Tyrosine Kinase Inhibitor
20%
Glucocorticoid
10%
Dexamethasone
10%
Interleukin 1
10%
RNA-Sequencing
10%
Chronic Myeloid Leukemia
10%
Cardiotoxin
10%
Pharmacovigilance
10%
Pyrin
10%
Carditis
10%
Alarmin
10%
Paquinimod
10%
Comorbidity
10%